Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) [Phase 3]

View source ↗

Summary

Phase 3 trial (RIBBON 2) assessed bevacizumab in combination with chemotherapy for previously treated metastatic breast cancer; the study is completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-09-24